Test Questions on Therapeutics ID Bergman – Flashcards
Unlock all answers in this set
Unlock answers| Penicillins: Mechanisms of Resistance |
|
| Penicillin G Route of Administration |
| IV |
| Penicillin VK Route of Administration |
| PO |
| Benzathine Penicillin G Route of Administration |
| Long Acting IM |
| Procaine Penicillin G Route of Administration |
| Short Acting IM |
| Oxacillin Route of Administration |
| IV |
| Nafcillin Route of Administration |
| IV |
| Dicloxacillin Route of Administration |
| PO |
| Ampicillin Route of Administration |
| IV |
| Amoxicillin Route of Administration |
| PO |
| Ticarcillin Route of Administration |
| IV |
| Piperacillin Route of Administration |
| IV |
| Why is Ticarcillin not used much in the hospital? |
| It is formulated with Na+ and is harmful to sick patients -- don't want to overload someone that has CHF with Na+ |
| Amoxicillin/Clavulanic Acid Route of Administration |
| PO |
| Ampicillin/Sulbactam Route of Administration |
| IV |
| Ticarcillin/Clavulanic Acid Route of Administration |
| IV |
| Piperacillin/Tazobactam Route of Administration |
| IV |
| Which antibiotics out of the penicillin classes do not need to be renally dosed? |
|
| Adverse Reactions of Penicillins |
Anaphylaxis (can't rechallenge with another beta lactam) Urticaria (hives) Drug Fever
|
| Cephalosporins: Mechanism of Resistance |
|
| Cefazolin Route of Administration |
| IV |
| Cephalexin Route of Administration |
| PO |
| Cefuroxime Route of Administration |
| IV/PO |
| Cefoxitin Route of Administration |
| IV |
| Cefotetan Route of Administration |
| IV |
| Ceftriaxone Route of Administration |
| IV |
| Cefotaxime Route of Administration |
| IV |
| Ceftazidime Route of Administration |
| IV |
| Cefepime Route of Administration |
| IV |
| Route of Elimination for Cephalosporins |
Renal
Exception: Ceftriaxone (biliary) Cefoperazone |
| Adverse Reactions of Cephalosporins |
Anaphylaxis Urticaria Drug Fever
Cefotetan, cefamandole, cefmetazole, cefoperazone, moxalactam Flushing, Vomiting - with concomitant alcohol consumption Increased INR |
| Carbapenems: Mechanism of Resistance |
|
| Carbapenems are excreted by which route? |
| Renal |
| Imipenem Route of Administration |
| IV |
| Meropenem Route of Administration |
| IV |
| Ertapenem Route of Administration |
| IV |
| Doripenem Route of Administration |
| IV |
| Which Carbapenem is administered with Cilastatin? |
Imipenem
|
| Adverse Reactions of Carbapenems |
high risk of C. difficile
Anaphylaxis, urticaria, drug fever Cross reaction with penicillins is higher than cephalosporins
|
| Aztreonam Route of Administration |
| IV |
| Aztreonam: Mechanism of Resistance |
| Extended Spectrum Beta Lactamases |
| Adverse Reactions of Aztreonam |
Weakly Immunogenic (due to one ring)
People with PCN allergy can use aztreonam |
| Aminoglycosides: MOA |
|
| Aminoglycosides: Mechanism of Resistance |
|
| Aminoglycosides route(s) of elimination |
Renal
Good for G- UTIs |
| Advantages of Once Daily Dosing of Aminoglycosides |
|
| Aminoglycosides can be used in synergy to fight what types of infections? |
G+ Infections MSSA Enterococci |
| Which aminoglycoside has the best Pseudomonas aeruginosa activity? |
| Tobramycin |
| Adverse Reactions of Aminoglycosides |
Aminoglycosides are Mean O'l Guys!
|
| Sulfamethoxazole: MOA |
|
| Trimethoprim: MOA |
|
| TMP-Sulfamethoxazole is the DOC for what infections? |
| Enterobacteriaceae |
| TMP-Sulfamethoxazole is the only PO drug for: |
| Staphylcoccus aureus (including MRSA) infections |
| Gentamicin Route of Administration |
| IV |
| Tobramycin Route of Administration |
| IV |
| Amikacin Route of Administration |
| IV |
| Streptomycin Route of Administration |
| IV |
| TMP-Sulfamethoxazole are eliminated by what routes? |
Renal ; Good for UTIs |
| Adverse Reactions of TMP-Sulfamethoxazole |
|
| Tetracyclines: MOA |
|
| Doxycycline Route of Administration |
| PO/IV |
| Indications of Tetracyclines |
|
| Adverse Reactions of Tetracyclines |
|
| Tigecycline: MOA |
|
| Tigecycline: Spectrum of Activity |
|
| Adverse Effects of Tigecycline |
| Nausea/Vomiting |
| Tigecycline Route of Administration |
| IV |
| When should you decrease maintenance dose of Tigecycline? |
| Patients with liver failure |
| Macrolides: MOA |
| Reversibly inhibits 50S ribosomal subunit |
| Adverse Effects of Macrolides |
| Nausea |
| Erythromycin Drug Interactions |
| Hepatic Cytochrome P450 - inhibits CYP 3A4 |
| Clarithromycin Drug Interactions |
| Hepatic Cytochrome P450 - inhibits CYP 3A4 |
| Major Problem with Telithromycin |
| Hepatic Failure |
| Quinolones: MOA |
| Inhibits bacterial Topoisomerase II and IV |
| Quinolones: Mechanism of Resistance |
|
| Ciprofloxacin Route of Administration |
| PO/IV |
| Levofloxacin Route of Administration |
| PO/IV |
| Moxifloxacin Route of Administration |
| PO/IV |
Which of the following are used for systemic AND urinary tract infections?
|
Ciprofloxacin and Levofloxacin are used for bacteremia and UTIs
Moxifloxacin is NOT used for UTIs Gemifloxacin is used for respiratory tract infections ONLY |
| Adverse Effects of Quinolones |
|
| What is a critical counseling point for a patient that is on a quinolone and is taking an iron supplement? |
|
| Clindamycin: MOA |
Lincosamide Antibiotic
Inhibits bacterial protein synthesis by binding to 50S ribosomal subunit |
| Route of Elimination for Clindamycin |
Hepatically Metabolized
No dosage adjustment for renal impairment |
| T/F: Clindamycin requires dosage adjustment in patients that are renally retarded |
False
Only patients that are hepatically retarded need dosage adjustments, b/c it is hepatically metabolized |
| Adverse Effects of Tigecycline |
|
| Metronidazole: MOA |
|
| Metronidazole Route of Elimination |
|
| Metronidazole Route of Administration |
| PO/IV |
| Adverse Effects of Metronidazole |
|
| Chloramphenicol: MOA |
|
| Chloramphenicol Route of Elimination |
| Primarily metabolized in liver |
| Adverse Effects of Chloramphenicol |
|
| Vancomycin Route of Administration |
| IV |
| Vancomycin Route of Elimination |
| Renal |
| Adverse Effects of Vancomycin |
"Red Man" Syndrome Hypotension
|
| Quinupristin/Dalfopristin: MOA |
| Dalfprostin has been shown to inhibit the early phase of protein synthesis while Quinupristin inhibits the late phase of protein synthesis |
| Quinupristin/Dalfopristin Route of Elimination |
|
| Quinupristin/Dalfopristin Spectrum of Activity |
|
| Adverse Effects of Quinupristin/Dalfopristin |
|
| Linezolid: MOA |
Oxazolidine Antibiotic
Binds to 23S rRNA of the 50S subunit --> prevents formation of a functional 70S initiation complex
-static against Staph. -cidal against Strep. |
| Linezolid Route of Elimination |
|
| Linezolid Spectrum of Activity |
MRSA VRE Strep. pneumoniae |
| Adverse Effects of Linezolid |
| Thrombocytopenia |
| Linezolid Drug Interactions |
| MAOI - may lead serotonin syndrome |
| Daptomycin: MOA |
Cyclic Lipopeptide Antibiotic
|
| Daptomycin Spectrum of Activity |
Aerobic G+ MRSA VRE |
| Adverse Effects of Daptomycin |
Myopathy
Not a selective agent and can target cell membranes of skeletal muscles |
| Daptomycin Route of Administration |
| IV |
| Telavancin Route of Administration |
| IV |
| Telavancin: MOA |
Lipoglycopeptide
|
| Adverse Effects of Telavancin |
Nephrotoxicity Black Box Warning: Birth Defects |
| Telavancin Route of Elimination |
| Renal |
| Chloramphenicol Route of Administration |
| IV |
| Azithromycin Route of Administration |
| PO/IV |
| Quinupristin/Dalfopristin Route of Administration |
| IV |
| Linezolid Route of Administration |
| PO/IV |